Loading
Yanuki
SUBCATEGORY FEED
FDA Drug Approval Controversy: Melanoma Drug Rejection Sparks Debate | Revolution Medicines' Pancreatic Cancer Drug Shows Promising Results in Trial | RFK Jr. Controversy: Tylenol, Autism, and Scientific Scrutiny | MAHA Report Cites Studies That Don’t Exist: A Controversy | FDA Drug Approval Controversy: Melanoma Drug Rejection Sparks Debate | Revolution Medicines' Pancreatic Cancer Drug Shows Promising Results in Trial | RFK Jr. Controversy: Tylenol, Autism, and Scientific Scrutiny | MAHA Report Cites Studies That Don’t Exist: A Controversy

Health / Science

FDA Drug Approval Controversy: Melanoma Drug Rejection Sparks Debate

The Food and Drug Administration (FDA) is facing scrutiny over its recent drug approval decisions, particularly the rejection of RP1, a melanoma drug candidate from Replimune. This decision has sparked debate among researchers, clinicians,...

FDA Drug Approval Controversy: Melanoma Drug Rejection Sparks Debate Image via CNBC
Watch CNBC's full interview with FDA Commissioner Marty Makary
Vaccines Infectious Diseases Public Health Wellness Weight Loss Cancer Nutrition Policy Celebrity Health Mental Health